In many gene expression signature analyses of clinical cancer samples, various types of IFN signatures represent a group of signatures that usually cluster well together to the exclusion of other signatures and therefore represent robust transcriptomic signals in cancer [16]. This evidence concerns the gene IFNA1 and cancer.